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Antibody-mediated parasite killing is considered the most effective host immune response
against extracellular trypanosome parasites. However, due to host-parasite co-evolution
pressure, these parasites have “learned” how to hijack the host immune system via the
development of immune evasion strategies. Hereby they prevent elimination and promote
transmission. In the past, our group has shown that African trypanosome parasites are able
to “shut down” the host B cell compartment, via the abolishment of the homeostatic B cell
compartment. In line with this, we have reported that trypanosome infections result in detri-
mental outcomes on auto-reactive and cancer B cells. To unravel the immune mechanisms
involved in these processes we adopted here a well-defined B cell vaccine model, i.e. the
thymo-dependent hapten-carrier NP-CGG (4-Hydroxy-3-nitrophenylacetyl-Chicken
Gamma Globulin) emulsified in Alum adjuvant. Results show that T. brucei infections abro-
gate the circulating titres of vaccine-induced CGG-specific as well as NP-specific IgG1+
antibodies, a hallmark of memory B cell responses in this model. This happens indepen-
dently of their affinity and IFNγ signalling. Next, we demonstrate that T. brucei infections
also induce a decrease of anti-NP IgG3+ antibodies induced by the administration of NP
coupled to Ficoll, a thymo-independent antigen. Confirming the non-specificity of the infec-
tion-associated immunopathology, this report also shows that trypanosome infections abol-
ish vaccine-induced memory response against malaria parasite in BALB/c mice. Together,
these data indicates that T. brucei infections impair every stages of B cell development,
including effector plasma B cells, independently of their specificity and affinity as well as the
host genetic background.
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Author summary
African trypanosomiasis is a fatal infectious disease caused by an extracellular parasite of
the Trypanosoma brucei species affecting both human and livestock. The most effective
immune response against this pathogen involves the production of antibodies by B cells.
However, experimental trypanosomiasis model in mice has demonstrated that this para-
site has evolved multiple immune evasion strategies targeting B cells. For instance, try-
panosomes abolish homeostatic B cell development, the adaptive protective response
against unrelated antigens as well as the progression of B-cell mediated arthritis and mul-
tiple myeloma. Here, we demonstrate that infection of resistant C57BL/6 mice impairs the
development of both thymo-dependent and -independent humoral response using the
well-characterized hapten-carrier NP-CGG (4-Hydroxy-3-nitrophenylacetyl-Chicken
Gamma Globulin) emulsified in Alum adjuvant and NP-Ficoll models, respectively. This
occurs independently of antigen specific B cell affinity and the pro-inflammatory IFNγ
cytokine signalling. Finally, trypanosoma abolishes the vaccine-induced memory response
against another life-threatening parasite, namely malaria, in Trypanosoma brucei suscepti-
ble BALB/c mice. In summary, African trypanosomiasis abrogates diverse plasma cell-
mediated effector B cell responses, independently of their specificity, affinity and host
genetic background.
Introduction
Extracellular protozoan African trypanosomes (AT) parasites are the causative agent of the
Sleeping Sickness in humans and Nagana in cattle and livestock [1,2]. The immune response
against AT parasites is mainly mediated by B cells and their production of antibodies [3]. B
cells start their development in the bone marrow from the common lymphoid progenitor
stage, which further give rise to several developmental stages of pre-pro-B, pro-B, pre-B and
eventually immature B cells [4]. At this stage, immature B cells migrate out of the bone marrow
and arrive via the circulation in the spleen as transitional B cells. These latter further differenti-
ate into mature marginal zone (MZ) B cells or follicular (Fo) B cells [5].
In order to counteract B cell-mediated immune responses, African trypanosomes have
evolved different immune-evasion strategies mainly focusing on the dampening of host B cell
activation and antibody-mediated response. For example, AT parasites are able to abolish B
cell homeostasis in lymphoid organs, such as the bone marrow and spleen. They also cause the
downregulation of detrimental B cell responses, e.g. autoimmune and malignant B cells [6–8].
Throughout the years, many murine B cell models have been developed. From these stud-
ies, two main classes of B cell responses have emerged, the thymo-dependent (TD) and -inde-
pendent (TI) models that either do, or do not, rely either on the presence of T cells. The
thymo-dependent hapten-carrier (4-hydroxy-3-nitrophenyl)-acetyl-chicken gamma globulin
(NP-CGG) emulsified in Alum adjuvant constitutes one of the most studied and well-charac-
terized model to study humoral/memory responses. For example, this model has been used for
decades to investigate the development of high affinity anti-NP IgG1+ antibodies that arose
from T cell-mediated proliferating B cells, that have undergone affinity maturation and selec-
tion in germinal center B cells [9]. In contrast, the thymo-independent NP hapten coupled to
Ficoll, a high molecular weight polysaccharide (NP-Ficoll) model, induces the rapid produc-
tion of low affinity anti-NP IgM+ and IgG3+ antibodies by MZ B cells in the absence of T cells
[10].
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Here we tested the capacity of the AT parasites to impede the development of various anti-
body-mediated B cell responses. In addition, we addressed the unbiased functional effect of
AT parasite induced B cell immunopathology using an anti-malaria coinfection model.
Together the data presented here demonstrate the general detrimental effect that trypanosome
have on the wider range of B cell populations in their host.
Material and Methods
Ethics statement
All experiments, maintenance and care of the mice complied with the European Convention
for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes
guidelines (CETS n˚ 123) and were approved by the Ethical Committee for Animal Experi-
ments (ECAE) at the Vrije Universiteit Brussel (Belgium) (Permit Number: 10-220-13).
Mice, parasites, immunization and treatment
Wild-type and IFNγ receptor-deficient C57BL/6 mice (8 to 10 weeks old, Janvier, France)
were immunized with 50μg of (4-hydroxy-3-nitrophenyl)-acetyl coupled to chicken gamma
globulin (NP36-CGG) (Biosearch Technologies, CA, USA), emulsified in Imject Alum
(Thermo Scientific, IL, USA) or with 30μg of NP67-Ficoll (Biosearch Technologies, CA, USA)
via intraperitoneal administration. A soluble boost 30μg of NP36-CGG in PBS was adminis-
tered 65 days post-immunization.
Clonal pleomorphic T. brucei AnTat 1.1E parasites have originally been obtained from
Prof. N. Van Meirvenne (Institute for Tropical Medicine, Belgium). Infected blood aliquods
(mouse) are stored at −80˚C. Female C57BL/6 mice (8- to 10-weeks old, Janvier, France) were
infected with 5000 AnTat1.1E trypanosomes (intraperitoneally (i.p.)) at day 20 and day 6 post
NP-CGG and NP-Ficoll administration, respectively.
P. berghei parasites genetically deficient in both plasmepsin-4 and bergheipain-2 (pm-4/bp2
dko P. berghei) were used in collaboration with Shahid Khan, The Netherlands. BALB/c mice
were vaccinated with 105 pm-4/bp2 dko P. berghei-infected red blood cells (iRBCs) i.p.. Six
months later, vaccinated mice were either left untreated or infected with 5000 AnTat1.1E try-
panosomes. Three weeks post-T. brucei infection, all mice were treated i.p. with diminazene
aceturate (Veriben, 40 mg/kg, Sigma Aldrich, St. Louis, MO, USA) in water, before being i.p.
rechallenged with wild-type P. berghei ANKA parasites expressing a GFP-luciferase fusion pro-
tein under the transcriptional control of the ama-1 promoter (105 infected RBCs) that allows
the monitoring of parasite load in blood, distribution and patterns of schizont sequestration in
live mice by real time in vivo imaging.
Blood was drawn via the tail at different time-points for serological analyses.
Enzyme-linked immunosorbant assay (ELISA) technique
96 well MicroWell MaxiSorp flat bottom plates (Sigma-Aldrich) were coated with 2μg/ml of
NP26-BSA, NP4-BSA (Biosearch Technologies, CA, USA) and CGG (Jackson ImmunoRe-
search) in PBS and incubated overnight at 4˚C. The following day the plates were washed with
PBS-Tween20 0.1% and blocked with PBS/BSA 1% for 3 hours at room temperature. After
removal of blocking solution, serial serum dilutions in PBS/BSA 0.1% were added to the plates
and incubated overnight at 4˚C. The next day, plates were washed with PBS-Tween20 0.1%
and incubated with anti-mouse IgG1, IgG3 and IgM isotypes coupled to Horse Radish peroxy-
dase (Lo-Imex, Louvain, BE) for 2 hours at 37˚C. After this incubation, plates were washed
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and revealed using a TMB kit (BD Biosciences). The reaction was stopped using a 2M sulfuric
acid solution and the plates were read at 450nm.
Statistics
The GraphPad Prism 4.0 software was used for statistical analyses (Two-way ANOVA or stu-
dent t-test). Values are expressed as mean ± SEM. Kaplan-Meier survival curve was analyzed
by means of the Log-Rank method. Values of p�0.05 are considered statistically significant,
where � = p�0.05, �� = p�0.01 and ��� = p�0.001. When low (NP26) and high (NP4) affinity
antibodies are compared on the same graph, � and � are for uninfected (square) and infected
(triangle) mice, respectively. When wild-type and IFNγ receptor-deficient mice are compared
on the same graph, � and � are for wild-type and IFNγ receptor-deficient mice, respectively.
Results
T. brucei infection affects conventional T cell-dependent humoral memory
responses
Previous results by our group have demonstrated that T. brucei infection abrogate vaccine-
induced protective memory response against a non-related pathogen, such as Bordetella per-
tussis, using a well-established human diphtheria, tetanus, and B. pertussis (DTPa) vaccination
model in mice [11]. However, a clear link between the abrogation of the memory response and
the disappearance of antigen-specific memory B cells has not been established. Therefore the
impact of trypanosomosis on the maintenance of antigen-specific IgG1+ memory B cells using
a well-characterized thymo-dependent (TD) antigen, i.e. (4-hydroxy-3-nitrophenyl)-acetyl
coupled to chicken gamma globulin (NP-CGG) emulsified in Alum, was investigated. In order
to avoid any impact on T. brucei parasite on the development of germinal center leading to
memory response development, mice were vaccinated approximately 3 weeks before infection
(Fig 1A). Before infection, anti-NP IgG1 antibody titers were analyzed on a NP26-BSA antigen
binding ELISA using sera from vaccinated mice (Fig 1B–black line). Forty days post-vaccina-
tion, corresponding to 20 days post-infection, the IgG1 titers of circulating anti-NP specific
antibodies were analyzed again in vaccinated-infected mice as well as control vaccinated mice
that were not exposed to a trypanosome challenge. The obtained data indicates that the ongo-
ing infection resulted in a drastic reduction of NP-CGG specific antibody titers (Fig 1B–green
lines). An identical trend is seen when NP-CGG specific antibody titers are measured in a
NP4-BSA antigen binding assay (Fig 1C). The comparison of the binding capacity of these cir-
culating anti-NP specific IgG1 antibodies on two differentially haptenated NP-BSA substrates,
namely NP26-BSA vs. NP4-BSA, provide an indication of antibody-target binding affinity.
Indeed, while both high and low affinity Abs bind to long-haptenated NP26-BSA (Fig 1B),
mainly high affinity Abs (but not low affinity Abs) bind to short-haptenated NP4-BSA (Fig
1C). Hence, the presented data demonstrates that that T. brucei infections reduce anti-NP-spe-
cific IgG1 antibodies independently of their affinity. This antibody suppression effect by T.
brucei infections also affects anti-carrier CGG IgG1 Ab titers, reinforcing the unbiased deplet-
ing capacity of AT infection (Fig 1D).
Experimental infections of C57BL/6 mice with pleomorphic T. brucei parasites usually
results in a fatal outcome after 4 to 5 weeks. Hence, if longer-term immune responses are to be
studied, a curative drug intervention step is needed. Here, we implemented a set-up in which
the trypanocidal diminazine diaceturate (Veriben) drug was administered at day 40 post-vacci-
nation in order to clear infection. This treatment does not restore the levels of low and high
affinity anti-NP IgG1 antibodies at day 65 post-vaccination (day 25 post cure) using the T cell
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dependent NP-CGG model (Fig 2A and 2B–green lines). However, the administration of a
NP-CGG saline boost at day 25 post-cure (day 65 post-vaccination) allows the levels of anti-
NP IgG1 antibodies to increase in previously infected mice within a week (D72), albeit the
observed titers do not reach the same levels as those observed in uninfected mice. The same
recover trend is observed for general anti-NP titers measured in a NP26-BSA antigen binding
ELISA (Fig 2C) as for the high affinity anti-NP4-BSA antibody titers (Fig 2D). In order to
make sure that the soluble NP-CGG administration was indeed boosting the remaining anti-
NP specific B cells at day 65 post-vaccination and not inducing a primary response due to the
presence of aggregates and/or lipopolysaccharide contamination, an add-on control experi-
ment was performed (S1 Fig). This latter confirms that soluble NP-CGG administration does
not induce any specific anti-NP IgG3 response compared to NP-Ficoll.
Previous results by our laboratory have identified a role of the pro-inflammatory cytokine
IFNγ in the early onset of follicular B cell apoptosis after T. brucei infection [12]. Here, using a
similar experimental approach, C57BL/6 wild-type (WT) and IFNγ-receptor (IFNγR)-defi-
cient mice were vaccinated with NP-CGG in Alum adjuvant and three weeks post-vaccination,
antibody titers were tested (Fig 3A). Both WT and IFNγR-deficient mice express similar levels
Fig 1. T. brucei infection dampens the primary humoral response against thymo-dependent antigens. C57BL/6 mice were immunized with NP-CGG
emulsified in Alum on day 0. Twenty days later serum was collected and mice were randomly divided in two groups. One group of vaccinated mice was infected
with T. brucei and the other one was left uninfected. At day fourty both groups were treated with Veriben, and on and day sixty-five they were both rechallenged
with soluble NP-CGG, respectively (A). Serial serum dilution levels of anti-NP IgG1 Abs on NP26-BSA and NP4-BSA (B,C) and anti-CGG IgG1 Abs (D) were
measured by ELISA on day 20 (before infection, black lines) and day 40 in uninfected (before Berenil treatment, open green squares) and infected (open green
triangles) mice. Graphs show the mean ± SEM from at least n = 6 mice per group and the data are representative of two independent experiments.
https://doi.org/10.1371/journal.pntd.0008358.g001
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of circulating high (NP4-BSA) and low affinity (NP26-BSA) anti-NP specific IgG1 antibodies at
day 21 post-vaccination (Fig 3B). Infection with T. brucei at day 21 post-vaccination induces a
similar decrease of low and high affinity anti-NP IgG1 antibodies in both WT and and IFNγR-
deficient mice at day 45 post-vaccination (day 24 p.i.) (Fig 3C and 3D). These results suggest
that the decrease of circulating anti-NP specific IgG1 levels occurred independently of IFNγ
signaling.
In summary, trypanosomosis affects T cell dependent memory immune responses as mea-
sured by the IgG1+ titers of both specific anti-hapten (NP) and anti-carrier (CGG) antibodies.
This happens independently of their affinity for the NP hapten and the presence of the pro-
inflammatory IFNγ cytokine.
Trypanosomosis hinders T cell-independent (TI) type 2 (TI-2) humoral
response
Trypanosome infections have been described in the past to be characterized by rapid T cell
independent antibody secretion, even preceding the first peak of infection that occurs around
Fig 2. Chemotherapy and soluble antigenic rechallenge do not restore humoral response against thymo-dependent antigens following T. brucei
infection. C57BL/6 mice were immunized with NP-CGG emulsified in Alum on day 0. Twenty days later, on group of vaccinated mice was infected with
T. brucei and the other one was left uninfected (A,B,C,D). At day fourty and sixty-five, both groups were treated with Veriben and rechallenged with
soluble NP-CGG, respectively. Serial serum dilution levels of anti-NP IgG1 Abs on NP26-BSA (A,C) and NP4-BSA (B,D) were measured by ELISA on day
40 (before Berenil treatment, black lines) and day 65 in uninfected (black and green squares, respectively) and infected (black and green triangles,
respectively) mice (A,B) and on day 72 (7 days post soluble rechallenge; squares represent uninfected mice and triangles represent infected mice) (C,D).
Graphs show the mean ± SEM from at least n = 6 mice per group and the data are representative of two independent experiments.
https://doi.org/10.1371/journal.pntd.0008358.g002
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day 4–5 post challenge [13–15]. This signals an effort by the host to contain infection before
systemic damage is being done by the parasite. Hence, we next investigated if trypanosomes
are able to modulate humoral responses against thymo-independent (TI) antigens. Immuniza-
tion with the same NP hapten, coupled to a TI carrier such as Ficoll, a large polysaccharide
with repeating antigenic determinants engaging multiple receptors on B cell surface is consid-
ered as a typical TI-2 antigen [16]. In contrast to the TD NP-CGG antigen used in the experi-
ments outlined above, the immune response against NP-Ficoll is dominated by NP-specific
IgM and IgG3 antibodies, which reach their maximum in the serum round day 7 and 14,
respectively. In the experimental setup outlined in Fig 4, mice were vaccinated once with
NP-Ficoll and challenged six days later with T. brucei parasites. A control group received the
vaccine without subsequent infection (Fig 4A). Vaccine induced antibody titers were measured
using the same NP26-BSA and NP4-BSA antigen ELISAs as used previously. At day 31 (day 25
post infection), a significant drop in the NP-specific IgG3 antibody titers is observed in the
infected group, whereas an antibody titre increase is observed in the vaccinated non-infected
group (Fig 4B). Surprisingly, the levels of NP-specific IgM antibodies are increased in the
Fig 3. T. brucei infection dampens the primary humoral response against thymo-dependent antigens independently of IFNγ signaling. IFNγR-deficient
and wild-type C57BL/6 mice were immunized with NP-CGG emulsified in Alum on day 0. Twenty-one days later, one group of vaccinated IFNγR-deficient and
wild-type C57BL/6 mice mice was infected with T. brucei and the other one was left uninfected (A). Serial serum dilution levels of anti-NP IgG1 Abs on NP26-
BSA (black line) and NP4-BSA (green line) were measured by ELISA on day 21 before infection in IFNγR-deficient (triangle) and wild-type (square) C57BL/6
mice (B). Serial serum dilution levels of anti-NP IgG1 Abs on NP26-BSA (C) and NP4-BSA (D) were measured by ELISA on day 45 (24 days post-infection) in
uninfected (black lines) and infected (green lines) IFNγR-deficient (triangle) and wild-type (square) C57BL/6 mice. Graphs show the mean ± SEM from at least
n = 6 mice per group and the data are representative of two independent experiments.
https://doi.org/10.1371/journal.pntd.0008358.g003
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vaccinated infected group compared to the uninfected group (Fig 4C). It should be noted how-
ever that other data obtained in experimental trypanosome models have shown the occurrence
of infection-induced cross-reactive antibodies against trinitrophenyl (TNP) [17]. This can
explain our results as the IgM+ antibodies detected here show some cross-reactivity with the
highly haptenated NP26-BSA coating antigen, whereas no cross-reactivity was observed for
IgG3+ antibodies (S2 Fig). This only becomes apparent when comparing anti-NP-BSA IgM
titers on both NP26- and NP4-BSA at day 31 in infection (Fig 4D). These results indicate indeed
that in infected mice, a substantial drop (~500-fold) in the circulating levels of high affinity
(NP4-BSA) anti-NP IgM titers (open green triangle) is observed when compared with low
affinity (NP26-BSA) anti-NP IgM levels (closed black triangle). In contrast, the difference in
uninfected mice between the levels of high (open green square) and low (close black square)
affinity anti-NP IgM is less than five-fold.
Together, these results demonstrated that T. brucei infection reduces both NP-specific IgM
and IgG3 levels during the development of a TI-2 humoral response against NP-Ficoll, and
that trypanosome parasites are able to induce low affinity cross-reactive anti-NP IgM
antibodies.
Fig 4. T. brucei infection hampers the humoral response against thymo-independent antigens. C57BL/6 mice were immunized with NP-Ficoll on day 0. Six
days later, one group of vaccinated mice was infected with T. brucei and the other one was left uninfected (A). Serial serum dilution levels of anti-NP IgG3 Abs (B)
and anti-NP IgM Abs (C) on NP26-BSA were measured by ELISA on day 6 (before infection, black lines) and day 31 in uninfected (open green squares) and
infected (open green triangles) mice. Serial serum dilution levels of anti-NP IgM Abs (D) on NP26-BSA (black lines) and on NP4-BSA (green lines) were measured
by ELISA on day day 31 in uninfected (squares) and infected (triangles) mice. Graphs show the mean ± SEM from at least n = 6 mice per group and the data are
representative of two independent experiments.
https://doi.org/10.1371/journal.pntd.0008358.g004
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Abolishment of vaccination-induced protection against malaria following
T. brucei infection occurs independently of host genetic background
In the past, we have shown the detrimental effect of experimental trypanosomosis on vaccine
recall responses, using the C57BL/6 mouse DTPa model [18]. To expand on this concept, and
to investigate how general the memory destruction is upon trypanosome challenge, we
included in this study a malaria vaccine model in BALB/c mice. BALB/c mice infected with
wild-type Plasmodium berghei (P. berghei) parasites succumb from severe anemia and uncon-
trolled parasitemia approximately two-to-three weeks post-infection [19]. In contrast, when
BALB/c mice are challanged with P. berghei parasites that are genetically deficient in both a
merozoite surface protein, msp-7, cells and a plasmepsin-4 (pm-4), long lasting protective and
cross-reactive immunity against a lethal rechallenge with wild-type P. berghei and P. yeolii par-
asites, is obtained [20,21]. This protective immunity is acting through antibody-mediated par-
asite clearance in the spleen [21]. Therefore, in order to assess the impact of T. brucei infection
on this B cell-mediated protective immunity, BALB/c mice were vaccinated with pm-4/bp2
dko P. berghei parasites [22] (Fig 5A). Six months later (~day 180), mice were infected with T.
brucei, while others were kept as uninfected controls. Three weeks into the infection, all mice
were treated with Veriben (~day 201), using a dose that cured the infection in trypanosome
challenged mice. Twenty-one days post-Veriben treatment (~day 222), all the vaccinated mice
were challenged with wild-type GFP-luciferase-expressing P. berghei parasites. Results demon-
strate that vaccinated and T. brucei-exposed BALB/c mice all were susceptible to the P. berghei
challenge (Fig 5B) succumb to the complication of the infection with 2 months following the
malaria exposure (Fig 5C). In contrast, vaccinated BALB/c mice that did not experience an
intermediate T. brucei infection that are still all alive 5 months later and showed complete anti-
malaria vaccine induced protection. These results confirmed that a T. brucei infection is capa-
ble of abrogating the efficacy of a B cell-mediated vaccine against other parasites such as
malaria, independently of the host genetic background.
Discussion
In order to establish a chronic infection in its host and to promote its transmission, African
trypanosomes have developed multiple strategies to evade host immune B cell response.
Among these, one of the most studied mechanisms is the antigenic variation process. This
mechanism allows the parasite to continuously change its antigenic coat in order to evade its
antibody-mediated elimination [23,24]. Other data have shown that African trypanosomes can
also directly target B cells, most likely by inducing their apoptosis in both the bone marrow
and spleen [6,18]. On top of the parasite impact on B cell homeostasis, our previous results
have shown that African trypanosomes can suppress the development of existing detrimental
B cells, such as autoimmune and cancer B cells. For example, T. brucei parasites blocks the
development of B cell-mediated collagen-induced arthritis in DBA prone mice, most likely by
affecting the survival of anti-type II collagen specific antibody [8]. As a result, the use of dimin-
azine diaceturate (Berenil) to treat trypanosomosis, restores the clinical signs of arthritis, most
likely by restoring specific autoimmune antibody levels. Also, African trypanosomes impact
the development of multiple myeloma, which are malignant plasma cells, by inducing their
intrinsic in vivo apoptosis, which was associated to the downregulation of the endogenous
unfolded protein response [7]. Using a well-characterized TD, namely NP-CGG emulsified in
Alum adjuvant, and TI, NP-Ficoll, model, we investigated here if T. brucei parasites were able
to affect both high and low antigen-specific B cells. Infection of NP-CGG immunized C57BL/6
mice demonstrates a similar impact of the parasite on both high and low affinity NP-specific
IgG1 antibody levels in serum as well as a negative impact on the systemic levels of anti-CGG
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antibodies. Here, the administration of Veriben did not restore the primary systemic levels of
anti-NP IgG1 antibodies. However, the secondary response induced by the administration of
NP-CGG in phosphate buffer restores some levels of both high and low affinity anti-NP IgG1
antibodies, but not to the same levels as in uninfected C57BL/6 mice. This results contrasts
with the effect of Berenil within the context of collagen-induced arthritis model [25]. These
results suggest that in case of vaccination, irreversible partial destruction of the memory cell
compartment took place during the trypanosome infection, resulting in an inability to deliver
a full recall response upon reencounter of the antigen. In our previously published collagen-
induced arthritis model, the partially destroyed auto-immune response was allowed to resur-
face after the suppressive effect of the trypanosome infection had been removed.
Previous results by our laboratory have identified a role of the pro-inflammatory cytokine
IFNγ in the early onset of follicular B cell apoptosis following trypanosomosis [12]. This cyto-
kine was also been implicated in other immunopathologies, such anemia of inflammation
[26], but also in the resistance to African trypanosome infection [27,28]. Using the NP-CGG
in Alum vaccination model, we demonstrate that the impact of the infection on circulating
anti-NP IgG1 antibodies is however independent of IFNγR signalling, which is an agreement
Fig 5. T. brucei infection blunts the existing vaccine-induced memory response aginst malaria parasites. BALB/c mice were immunized with pm-4/
bp2-deficient P. berghei on day 0. One hundred and eighty days later, one group of vaccinated mice was infected with T. brucei and the other one was left
uninfected. At day two hundred and one and two hundred and twenty-two, both groups were treated with Veriben and rechallenged with GFP-P.
berghei, respectively (A). Evolution of GFP+ infected red blood cells (B) and survival (C) of infected (triangle) and uninfected (square) vaccinated mice.
Graphs show the mean and scattered plots from at least n = 4 mice per group and the data are representative of two independent experiments.
https://doi.org/10.1371/journal.pntd.0008358.g005
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with another study investigating the mechanism implicated in B cell death in after T. brucei
infection [29].
T. brucei infection of C57BL/6 mice inoculated with the TI antigen NP-Ficoll also has a
drastic negative impact on the systemic levels of anti-NP IgG3 antibodies 25 days post-infec-
tion (day 31 post NP-Ficoll) compared to uninfected mice. In contrast, the level of circulating
anti-NP IgM antibodies increased in infected vs. uninfected mice. This result could be
explained by the generation of cross-reactive anti-NP antibodies following T. brucei-induced
polyclonal B activation, as a clear difference between systemic levels of high and low anti-NP
IgM is observed in infected mice. Similar results were already described in the context of T.
vivax infection [17]. These results might be linked to the fact that TI antigens, such as type 2 TI
antigen NP-Ficoll, mainly activate MZ B cells to produce IgG3 and IgM antibodies [30,31] and
that these latter are depleted following infection [18].
Together, these results demonstrate the African trypanosomes infection can impact the lev-
els of systemic levels of anti-NP IgG3 and IgM antibodies in response to the administration of
a type 2 TI antigen, such as NP-Ficoll.
Finally, previous results from our laboratory have shown that T. brucei infection can abro-
gate the vaccine-induced protective immune response against a non-related pathogen such as
B. pertussis [18]. However, the direct effect of African trypanosome infection on B cells was
not defined within this experimental set-up. Therefore, using an experimental B cell-depen-
dent model of vaccination against malaria, we showed now that African trypanosome infection
was able to abolish the B cell-mediated protection against live malaria challenge in susceptible
mice. In various animal models, other pathogens, such as Salmonella bacteria and measles
virus infection, were also able to interfere with the development of efficient humoral immune
responses [32,33]. If potentially applicable to humans, this detrimental effect of African try-
panosomes could have important implications in endemic areas, in particular when consider-
ing a future anti-malaria vaccine application. While such vaccine is not available yet, there is
an ongoing effort to develop such intervention strategy that could help the global eradication
of malaria. Taken our results, it will be important to ensure that such approach is also effective
in HAT endemic areas, which largely overlap with malaria endemic areas in sub-Sahara Africa.
In humans, studies that address the impact of trypanosome infections on host B cell immunity
and vaccine induced memory are virtually absent. One publication reported a significant
lower concentrations of anti-measles Abs in vaccinated HAT patients vs. vaccinated HAT-neg-
ative individuals [34]. The differences between these two groups of patients persisted even
seven months post-trypanocidal treatment. However, the impact of this decrease was not
tested during a new encountering with the causative virus. Neither was it tested which propor-
tion of the remaining anti-measles titres resulted from parasite-mediated polyclonal low-affin-
ity Ab activation. More recently, human measles infection was also shown to compromise
immune memory to previously encountered pathogens due to depletion of previously
expanded B memory clones [33]. In addition, malaria parasite and HIV are also able to
decrease the potential of memory B cells to differentiate into plasma B cells [35,36]. At this
stage however, the exact mechanisms leading to the abrogation of different specific humoral
responses following T. brucei infection remain to be unveiled, as both direct (e.g. decreasing
half-life of specific antibodies in combination with B cell apoptosis) as well as indirect events
(e.g. a modulation of lymphoid microenvironment or any other secondary infection-associ-
ated effector mechanism that could affect memory B cell functions), could be involved.
Together, these results confirm a detrimental role of African trypanosomes infection on B
cell homeostasis and their effector functions and these data could have huge implications in
terms of vaccine design and strategy in endemic areas.
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Supporting information
S1 Data. This prism file summarizes all the raw data required to design the different fig-
ures presented in this article.
(PZF)
S1 Fig. Impact of soluble NP-CGG administration on primary specific anti-NP response.
C57BL/6 mice were immunized with NP-Ficoll (square) or NP-CGG (triangle) on day 0. Serial
serum dilution levels of anti-NP IgG3 Abs on NP26-BSA were measured by ELISA on day 7.
Graphs show the mean ± SEM from at least n = 4 mice per group and the data are representa-
tive of one independent experiment.
(TIF)
S2 Fig. Cross-reactive potential of anti-T. brucei antibody. C57BL/6 mice were infected
with T. brucei. Serial serum dilution levels of anti-NP IgM (filled square) and IgG3 (filled tri-
angle) Abs from pooled (n = 3) day 6-infected and uninfected mice were measured. The data
are representative of two independent experiments.
(TIF)
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